How we made the decision

We check our guidelines regularly to ensure they remain up to date. We based the decision on a surveillance review of NICE's guideline on osteoarthritis (NICE guideline CG177) in 2017.

For details of the process and update decisions that are available, see ensuring that published guidelines are current and accurate in developing NICE guidelines: the manual.

Evidence

We found 292 studies in a search for randomised controlled trials and systematic reviews published between 7 May 2013 and 11 Feb 2017. One relevant study was identified after the end search date. We also included 3 relevant studies from a total of 155 identified by members of the guideline committee who originally worked on this guideline.

From all sources, we considered 295 studies to be relevant to the guideline.

We also checked for relevant ongoing research, which will be evaluated again at the next surveillance review of the guideline.

See appendix A: summary of evidence from surveillance for details of all evidence considered, and references.

Views of topic experts

We considered the views of topic experts, including those who helped to develop the guideline.

Views of stakeholders

Stakeholders are consulted only if we decide not to update the guideline following checks at 4 and 8 years after publication. Because this surveillance decision was to update, we did not consult on the decision.

See ensuring that published guidelines are current and accurate in developing NICE guidelines: the manual for more details on our consultation processes.

NICE Surveillance programme project team

Kay Nolan
Associate Director

Martin Allaby
Consultant Clinical Adviser

Judith Thornton
Technical Adviser

Lynne Kincaid
Technical Analyst

The NICE project team would like to thank the topic experts who participated in the surveillance process.

ISBN: 978-1-4731-2633-6


This page was last updated: 22 August 2017